The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Association Between Cell-Free Hemoglobin, Acetaminophen, and Mortality in Patients With Sepsis: An Observational Study*
Open accessAbstract
OBJECTIVE: To determine the association of circulating cell-free hemoglobin with poor clinical outcomes in patients with sepsis and to characterize the potential protective effects of acetaminophen, an inhibitor of hemoprotein-mediated oxidation. DESIGN: Retrospective observational study. PATIENTS: A total of 391 critically ill patients with sepsis in multiple ICUs in an academic tertiary care hospital. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Nonsurvivors had significantly higher plasma cell-free hemoglobin concentrations (median 20mg/dL, interquartile range 10-40) measured on enrollment compared to survivors (10mg/dL, interquartile range 10-30, p = 0.002). After controlling for potential confounders, patients with higher cell-free hemoglobin concentrations were significantly more likely to die in the hospital (odds ratio 1.078, 95% confidence interval 1.012-1.149, p = 0.02). In addition, receiving acetaminophen in the setting of increased cell-free hemoglobin was independently associated with a protective effect against death (odds ratio 0.48, 95% confidence interval 0.25-0.91, p = 0.026) and lower plasma concentrations of the lipid peroxidation product F2-isoprostanes (18.5 pg/mL, interquartile range 9-22.2) compared to no acetaminophen (42 pg/mL, interquartile range 29.7-86, p = 0.009). CONCLUSIONS: In critically ill patients with sepsis, elevated concentrations of circulating cell-free hemoglobin are independently associated with an increased risk of death. Acetaminophen may exert a protective effect by reducing cell-free hemoglobin-induced oxidative injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The clinical relevance of this pathologic process is strongly supported by the finding that accumulation of extracellular hemoglobin is associated with higher risk of death from severe sepsis [193,194].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [193]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 3×
“various vascular beds (1, 2, 6, 8, 9), neutrophil activation (10),”
BackgroundCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Natanson, C., Kern, S. J., Lurie, P., Banks, S. M., & Wolfe, S. M. (2008) · JAMA · doi:10.1001/jama.299.19.jrv80007 · Cited by 622
Donadee, C., Raat, N. J. H., Kanias, T., Tejero, J., Lee, J. S., Kelley, E. E., Zhao, X., Liu, C., Reynolds, H., Azarov, I., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.008698 · Cited by 572 · cited 2×
“various vascular beds (1, 2, 6, 8, 9), neutrophil activation (10),”
BackgroundA Central Role for Free Heme in the Pathogenesis of Severe Sepsis
Larsen, R., Gozzelino, R., Jeney, V., Tokaji, L., Bozza, F. A., Japiassú, A. M., Bonaparte, D., Cavalcante, M. M., Chora, Â., Ferreira, A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001118 · Cited by 483 · cited 2×
“org 785 of haptoglobin, hemopexin, or heme oxygenase-1 (18).”
BackgroundMinneci, P. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25040 · Cited by 331 · cited 2×
“various vascular beds (1, 2, 6, 8, 9), neutrophil activation (10),”
BackgroundNeutrophil activation by heme: implications for inflammatory processes
Graça-Souza, A. V., Arruda, M. A. B., de Freitas, M. S., Barja-Fidalgo, C., & Oliveira, P. L. (2002) · Blood · doi:10.1182/blood.v99.11.4160 · Cited by 295
Research works printed but not linked: 1
- Reeder, 2004, Antioxid Redox Signal, 6, 954
Cited by
The isoprostanes—25 years later
Milne, G. L., Dai, Q., & Roberts, L. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.007 · Cited by 335
“The antioxidant properties of acetaminophen were recently studied in a human population with sepsis [183].”
BackgroundSelf-citationAn extracorporeal blood-cleansing device for sepsis therapy
Kang, J. H., Super, M., Yung, C. W., Cooper, R. M., Domansky, K., Graveline, A. R., Mammoto, T., Berthet, J. B., Tobin, H., Cartwright, M. J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3640 · Cited by 321
Clinical trials in acute respiratory distress syndrome: challenges and opportunities
Matthay, M. A., McAuley, D. F., & Ware, L. B. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30188-1 · Cited by 284
Self-citationThe Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
Acute respiratory distress syndrome
Wick, K. D., Ware, L. B., & Matthay, M. A. (2024) · BMJ · doi:10.1136/bmj-2023-076612 · Cited by 212
“147 148-150 Early in the covid-19 pandemic, some experts posited that covid-19 ARDS represented a distinct pathophysiological and clinical entity with unique sub-phenotypes, 151 in some cases warranting a fundamentally different management approach from “traditional” ARDS.”
Self-citation
Metadata
- Authors
- Janz, D. R., Bastarache, J. A., Peterson, J. F., Sills, G., Wickersham, N., May, A. K., Roberts, L. J., & Ware, L. B.
- Affiliations
- Vanderbilt University (US)
- Venue
- Critical Care Medicine
- Published
- 2013-03
- Volume
- 41
- Issue
- 3
- Pages
- 784-790
- ISSN
- 0090-3493 (ISSN-L)
- PMC
- PMC3578977
- OpenAlex
- W2038586688
- Cited by
- 169
- References
- 28
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 29 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 6 · 2019: 8 · 2018: 12 · 2017: 9 · 2016: 11 · 2015: 10 · 2014: 15 · 2013: 10
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K24HL103836, HL 090785, HL103836, K08HL090785, U01HL081332, R21HL112656, T32HL087738)
- National Institute of General Medical Sciences (GM 42056, P01GM015431, R01GM042056, R37GM042056)
- National Center for Research Resources (UL1RR024975)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- free hemoglobin, sepsis, paracetamol, mortality, critically ill patients, oxidative stress, lipid peroxidation, F2-isoprostanes, prognostic factors
- MeSH terms
- Acetaminophen, Aged, Cell-Free System, Female, Hemoglobins, Humans, Intensive Care Units, Male, Middle Aged, Retrospective Studies, Confidence Intervals, Logistic Models, Odds Ratio, Hospital Mortality, Oxidative Stress, Analgesics, Non-Narcotic, Sepsis, F2-Isoprostanes, Qualitative Research, Tertiary Care Centers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.